Cardiology

Top Story

DCB bests plain balloon angioplasty for TLR risk reduction in patients with femoropopliteal artery disease

August 25, 2016

In patients with femoropopliteal artery disease, treatment with a drug-coated balloon yielded a significantly reduced risk for target lesion revascularization at 12 months compared with conventional plain balloon angioplasty, with no effect on all-cause mortality, according to a systematic review and meta-analysis.

Researchers identified eight randomized trials that assessed the efficacy of drug-coated balloons (DCB) vs. plain balloon (PB) angioplasty for treatment of femoropopliteal artery disease through Dec. 1, 2015. The eight trials were Biolux P-I, FAIR, FemPac, In.PACT SFA, LEVANT 1, LEVANT 2, PACIFIER and THUNDER.

In the Journals

Late-onset asthma may increase risk for CV events

August 25, 2016
Adults with late-onset asthma were 57% more likely to experience a CV event compared with those without asthma, researchers reported in the Journal of the American
In the Journals

High drug prices result of government protection in US

August 25, 2016
The high cost of prescription drugs in the United States is the result of drug manufacturers being granted government-protected monopolies, according to data published…
In the Journals

PCI infrequent in patients with AF at moderate to high risk for stroke

August 25, 2016
In the ROCKET AF trial, PCI was performed in less than 1% of patients with atrial fibrillation and moderate to high risk for stroke. Most patients remained on…
In the Journals

Young women with stable CAD susceptible to mental stress-induced myocardial ischemia

August 25, 2016
Among patients with CHD, the incidence of mental stress-induced myocardial ischemia in women aged 50 years and younger was fourfold higher compared with men of a similar…
More News Headlines »
morganatic-roan